Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
UDG Healthcare sells ‘specials’ businesses

Dublin-based UDG Healthcare has sold its ‘specials’ businesses and Arjun Products to Professional Compounding Centers of America for £23.5 million.
‘Specials’ are unlicensed medicines that are made-to-order for individual patients.
The specials businesses UDG Healthcare has sold are The Specials Laboratory Holdings and Craig & Hayward, which both manufacture and distribute specials for the community pharmacy and hospital markets in the UK.
Arjun Products, which makes dermatology creams, mineral supplements and ear and nose drops, was also sold as part of the transaction.  
The carrying value of all three assets is £33.5 million, marking a disposal loss of £10 million for UDG Healthcare.
The three businesses generated profits before interest and tax of £2.6 million for the year ended 30 September 2013.
UDG Healthcare decided to part with these businesses as it decided that they fell outside the group’s core areas.
The money made from the sale will be used to fund future acquisitions according to the group’s statement.


Related articles:

Posted on: 12/02/2014

Latest news stories

03/06/2020
In Scotland, more people have died from Covid-19 in care homes than in hospital, according to the latest official figures.
02/06/2020
UK primary care REIT Assura is set to start work this month on a new GP surgery in Ware, Hertfordshire.
02/06/2020
Elysium Neurological, part of Elysium Healthcare, has opened a specialised neurobehavioural rehabilitation service for adults in Swindon.
02/06/2020
DenScreen, a partnership between dental and infectious disease experts, has launched a new service to tackle and minimise the risk of Covid-19 in the dental workplace.
01/06/2020
The government’s abrupt decision announced at the weekend that 2.2 million people in England with medical conditions that put them at greater risk from Covid-19 can now leave their homes has left patients anxious and confused.



HealthInvestor blog
April was indeed the cruellest month, to paraphrase T.S.Eliot. The tragedy of so many lives lost will resonate for decades and we will long remember the bitter chill from the sinister shadow of Covid-19.

Click here to view the HealthInvestor blog


We could be forgiven for failing to remember that Brexit happened just four short months ago but the implications for the sector are still very much here to stay. Marie Manley and Will Holmes, of Sidley Austin investigate the future for life sciences
Helen Costa is the founder of Cornerstone, a social enterprise focused on improving the lives of children and families touched by the care system. She talks to Jenna Lomax about challenging the consultancy industry and how virtual reality can improve vulnerable lives
Helen Nugent, a barrister in the clinical negligence team at Temple Garden Chambers, outlines what operators need to know about the provision and use of PPE at a time of crisis
With the technologies now available to us, there is no reason government initiatives to track and control the spread of Covid-19 must come at the expense of personal data privacy, writes R3’s Isabelle Corbett
The Covid-19 outbreak has had a significant impact on the UK healthcare real estate investment market. Kathy Oxtoby reviews the landscape

Click here to search all feature articles


my images

Social care

Helen Costa is the founder of Cornerstone, a social enterprise focused on improving the lives of children and families touched by the care system. She talks to Jenna Lomax about challenging the consultancy industry and how virtual reality can improve vulnerable lives
Read more


Christie + Co


Investment amid Covid-19
The Covid-19 virus has put the fragility of the global economic system under the microscope. But Jenna Lomax finds out why some leading industry figures believe the healthcare sector will be able to quickly bounce back from the economic freeze
Read more